Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Topoisomerases in Immune Cell Development and Function. | J Immunol | 2023 | 36596219 | PubTator, text mining | PubMed |
| Multi-OMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells. | iScience | 2023 | 36590899 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing uncovers dynamic roadmap and cell-cell communication during buffalo spermatogenesis. | iScience | 2023 | 36582818 | PubTator, text mining | PubMed |
| Chromatin modifiers: A new class of pollutants with potential epigenetic effects revealed by in vitro assays and transcriptomic analyses. | Toxicology | 2023 | 36581016 | PubTator, text mining | PubMed |
| The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications. | Nat Rev Urol | 2023 | 36543976 | PubTator, text mining | PubMed |
| Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase IIβ Expression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide. | J Pharmacol Exp Ther | 2023 | 36410793 | PubTator, text mining | PubMed |
| Discovery of novel DNA-damaging agents through phenotypic screening for DNA double-strand break. | Cancer Sci | 2023 | 36385507 | PubTator, text mining | PubMed |
| Furoquinoline and bisindole alkaloids from the roots of Teclea nobilis and their in-silico molecular docking analysis. | Z Naturforsch C J Biosci | 2023 | 36367257 | PubTator, text mining | PubMed |
| Applying CRISPR-Cas9 screens to dissect hematological malignancies. | Blood Adv | 2023 | 36355853 | PubTator, text mining | PubMed |
| Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C. | Neuro Oncol | 2023 | 36334050 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer. | Mol Ther | 2023 | 35965411 | PubTator, text mining | PubMed |
| Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs). | IUBMB Life | 2023 | 35499745 | PubTator, text mining | PubMed |
| Loss of SORCS2 is Associated with Neuronal DNA Double-Strand Breaks. | Cell Mol Neurobiol | 2023 | 34741697 | PubTator, text mining | PubMed |
| PSICalc: a novel approach to identifying and ranking critical non-proximal interdependencies within the overall protein structure. | Bioinform Adv | 2022 | 36699404 | PubTator, text mining | PubMed |
| Ticagrelor reduces doxorubicin-induced pyroptosis of rat cardiomyocytes by targeting GSK-3β/caspase-1. | Front Cardiovasc Med | 2022 | 36684601 | PubTator, text mining | PubMed |
| Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases. | Viruses | 2022 | 36680145 | PubTator, text mining | PubMed |
| Ethnomedicinal Uses, Phytochemistry, and Therapeutic Potentials of Litsea glutinosa (Lour.) C. B. Robinson: A Literature-Based Review. | Pharmaceuticals (Basel) | 2022 | 36678501 | PubTator, text mining | PubMed |
| The Role of PARP1 and PAR in ATP-Independent Nucleosome Reorganisation during the DNA Damage Response. | Genes (Basel) | 2022 | 36672853 | PubTator, text mining | PubMed |
| Application of Single-Cell RNA Sequencing in Ovarian Development. | Biomolecules | 2022 | 36671432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=17